VEGFA and small cell lung carcinoma: Mechanistical studies revealed that VEGF-A was prone to elevate the co-expression of TIM-3 as an inhibitory receptor on T cells, suggesting the immunosuppressive role of VEGF in SCLC patients in the presence of anti-PD-1 therapy.